John P. Vasilakos

6.5k total citations · 2 hit papers
47 papers, 4.7k citations indexed

About

John P. Vasilakos is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, John P. Vasilakos has authored 47 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 7 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in John P. Vasilakos's work include Immunotherapy and Immune Responses (23 papers), Immune Response and Inflammation (22 papers) and Immune Cell Function and Interaction (18 papers). John P. Vasilakos is often cited by papers focused on Immunotherapy and Immune Responses (23 papers), Immune Response and Inflammation (22 papers) and Immune Cell Function and Interaction (18 papers). John P. Vasilakos collaborates with scholars based in United States, China and France. John P. Vasilakos's co-authors include Mark A. Tomai, Şefik Ş. Alkan, Ross M. Kedl, Xiaohong Qiu, Sheila J. Gibson, Keith Gorden, Kevin Gorski, William C. Kieper, Cory L. Ahonen and Michael E. Danielson and has published in prestigious journals such as Nature, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

John P. Vasilakos

47 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activation of the innate immune receptor Dectin-1 upon formation of a ‘phagocytic synapse’

2011 652 citations Nandita Bose, Anissa Chan et al. profile →
Synthetic TLR Agonists Reveal Functional Differences between Human TLR7 and TLR8

2005 563 citations Keith Gorden, Kevin Gorski et al. The Journal of Immunology profile →

Peers

Countries citing papers authored by John P. Vasilakos

Since Specialization

Citations

This map shows the geographic impact of John P. Vasilakos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Vasilakos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Vasilakos more than expected).

Fields of papers citing papers by John P. Vasilakos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Vasilakos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Vasilakos. The network helps show where John P. Vasilakos may publish in the future.

Co-authorship network of co-authors of John P. Vasilakos

This figure shows the co-authorship network connecting the top 25 collaborators of John P. Vasilakos. A scholar is included among the top collaborators of John P. Vasilakos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. Vasilakos. John P. Vasilakos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Live-Attenuated VEEV Vaccine Delivered by iDNA Using Microneedles Is Immunogenic in Rabbits 2022 ·Frontiers in Tropical Diseases ·Irina Tretyakova, Mark A. Tomai, John P. Vasilakos, Peter Pushko	4
2	On the Creation of a Safe Operating Envelope for Ships 2018 ·SNAME Maritime Convention ·(unknown), Michael P. Eaton, (unknown), John P. Vasilakos	1
3	Toll-like Receptor 4 Ligands Down-regulate Fcγ Receptor IIb (FcγRIIb) via MARCH3 Protein-mediated Ubiquitination 2015 ·Journal of Biological Chemistry ·(unknown), Li Ren, (unknown), Huiqing Fang, Xiaokui Mo, John P. Vasilakos, Gregory N. Dietsch, Robert M. Hershberg, Susheela Tridandapani, Jonathan P. Butchar	16
4	Combination therapy targeting toll like receptors 7, 8 and 9 eliminates large established tumors 2014 ·Journal for ImmunoTherapy of Cancer ·(unknown), John P. Vasilakos, Debra Tross, Dmitri Smirnov, Dennis M. Klinman	60
5	Binding of Soluble Yeast β-Glucan to Human Neutrophils and Monocytes is Complement-Dependent 2013 ·Frontiers in Immunology ·Nandita Bose, Anissa Chan, (unknown), (unknown), Xiaohong Qiu, Richard M. Walsh, (unknown), (unknown), Keith Gorden, (unknown), (unknown), Michael E. Danielson, (unknown), Andrew S. Magee, Myra L. Patchen, John P. Vasilakos	55
6	Characterization of Mucosal Candida albicans Biofilms 2009 ·PLoS ONE ·Anna Dongari‐Bagtzoglou, H. Kashleva, Prabhat Dwivedi, Patricia I. Diaz, John P. Vasilakos	166
7	TLR7 Agonist 852A Inhibition of Tumor Cell Proliferation Is Dependent on Plasmacytoid Dendritic Cells and Type I IFN 2008 ·Journal of Interferon & Cytokine Research ·Jon R. Inglefield, Calin Dan Dumitru, Şefik Ş. Alkan, Sheila J. Gibson, Kenneth E. Lipson, Mark A. Tomai, Christopher J. Larson, John P. Vasilakos	30
8	Comparison of human B cell activation by TLR7 and TLR9 agonists 2008 ·BMC Immunology ·(unknown), John P. Vasilakos, (unknown), (unknown), Kenneth E. Lipson, Şefik Ş. Alkan, Woubalem Birmachu	100
9	Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells 2007 ·Journal of Translational Medicine ·Venky Ramakrishna, John P. Vasilakos, Joseph D. Tario, Marc A. Berger, Paul K. Wallace, Tibor Keler	47
10	Oligodeoxynucleotides Differentially Modulate Activation of TLR7 and TLR8 by Imidazoquinolines 2006 ·The Journal of Immunology ·(unknown), Xiaohong Qiu, (unknown), (unknown), John P. Vasilakos, Şefik Ş. Alkan	72
11	Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists 2006 ·International Immunology ·Kevin Gorski, (unknown), (unknown), (unknown), (unknown), William C. Kieper, Keith Gorden, Jeffrey S. Miller, John P. Vasilakos, Mark A. Tomai, Şefik Ş. Alkan	130
12	Administration of a dual toll-like receptor 7 and toll-like receptor 8 agonist protects against influenza in rats 2006 ·Antiviral Research ·(unknown), Gary R. Burleson, (unknown), John P. Vasilakos, Mark A. Tomai, (unknown), Felicia R. Cochran, Susan L. Woulfe, Richard L. Miller	60
13	Synthetic TLR Agonists Reveal Functional Differences between Human TLR7 and TLR8 breakdown → 2005 ·The Journal of Immunology ·Keith Gorden, Kevin Gorski, Sheila J. Gibson, Ross M. Kedl, William C. Kieper, Xiaohong Qiu, Mark A. Tomai, Şefik Ş. Alkan, John P. Vasilakos	563
14	The Immune Response Modifier and Toll-Like Receptor 7 Agonist S-27609 Selectively Induces IL-12 and TNF-α Production in CD11c+CD11b+CD8− Dendritic Cells 2003 ·The Journal of Immunology ·(unknown), (unknown), Michael J. Reiter, (unknown), John P. Vasilakos, Ross M. Kedl	86
15	Adjuvant Activities of Immune Response Modifier R-848: Comparison with CpG ODN 2000 ·Cellular Immunology ·John P. Vasilakos, (unknown), Sheila J. Gibson, (unknown), (unknown), Michael J. Reiter, Michael Smith, Mark A. Tomai	124
16	Contribution of the ICE Family to Neurodegeneration 1998 ·Annals of the New York Academy of Sciences ·Brenda D. Shivers, Peter A. Boxer, Karen M. Keane, Nancy C. Kupina, (unknown), Gerald P. Schielke, Mark G. Vartanian, John P. Vasilakos	3
17	Inhibition of the interleukin-1β converting enzyme family rescues neurons from apoptotic death 1997 ·Molecular Psychiatry ·Timothy Lynch, John P. Vasilakos, Kadee J. Raser, Karen M. Keane, Brenda D. Shivers	18
18	Caspase-3/CPP32-like activity is not sufficient to mediate apoptosis in an IL-2 dependent T cell line 1997 ·APOPTOSIS ·John P. Vasilakos, Timothy Lynch, Tariq Ghayur, David A. Giegel, Maxine Fico Santoro, Brenda D. Shivers	4
19	Enhancement of CTL Response Induced by a Viral Peptide Using Cationized BSA, a Th1-Stimulating Adjuvant 1994 ·Viral Immunology ·John P. Vasilakos, J. Gabriel Michael	2
20	Interleukin‐1β dissociates β‐amyloid precursor protein and β‐amyloid peptide secretion 1994 ·FEBS Letters ·John P. Vasilakos, (unknown), Mark R. Emmerling, (unknown), Robert E. Davis, (unknown), Brenda D. Shivers	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact